Mdxhealth Receives Compliance Notification from Nasdaq
Mdxhealth announced that the company received a notification letter from Nasdaq, notifying the company that it is not in compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550 for continued listing on Nasdaq. This press release is issued pursuant to Nasdaq Listing Rule 5810, which requires prompt disclosure upon the receipt of a deficiency notification.
